FDA adjusts maximum civil money penalties to account for inflation.
FDA declares personalized medicine “has clearly arrived.”
Scholar proposes a manufacturers’ excise tax to fund obesity-prevention efforts.
Agency hopes a strategic plan and proposed rule will protect patients from delayed treatment.
Supporters of legislation argue FDA will not cabin its regulatory power on its own.
Recent Supreme Court rulings provide insight into variable tort litigation outcomes.
The regulatory review process engages a wide range of actors.
State governments still have great power to negotiate favorable outcomes.
Better tools are needed to evaluate regulatory effectiveness.
New legislation will impose restrictions on abortion clinics and physicians.